StonvexLoading…
StonvexStonvexStonvexCore line items from NHC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.47B | $1.25B | $1.09B | $1.03B |
Operating Income | $128.35M | $89.89M | $57.46M | $31.90M |
Net Income | $120.02M | $101.93M | $66.80M | $22.45M |
EPS (Diluted) | $7.67 | $6.53 | $4.34 | $1.45 |
Total Assets | $1.53B | $1.52B | $1.31B | $1.28B |
Total Liabilities | $451.90M | $541.27M | $400.32M | $397.94M |
Cash & Equivalents | $92.83M | $76.12M | $107.08M | $58.67M |
Free Cash Flow OCF − CapEx | $148.63M | $79.70M | $83.31M | $-21.46M |
Shares Outstanding | 15.54M | 15.45M | 15.35M | 15.36M |